Scientist speculate that the regulation of thyroid function could be a potentially novel therapeutic target for the treatment of diabetes. The researchers base their hypothesis on evidence from a recent study that revealed that free triiodothyronine (T3) is associated with both basal and glucose-stimulated insulin secretion in people with prediabetes who are euthyroid. suppversity | Oda et al. Positive association of free triiodothyronine with pancreatic β-cell function in people with prediabetes. Diabetic Medicine (2014).
Posted on: Wed, 01 Oct 2014 07:01:20 +0000